iPSC-derived Monocytes; DYS0100 from ATCC

Supplier Page

Supplier Page from
ATCC for
iPSC-derived Monocytes; DYS0100

Request Info

Description

iPSC-derived Monocytes; DYS0100 are induced pluripotent stem cells that have been differentiated into CD14+ monocytes. These cells can be used in cancer immunology research, drug development, and toxicity screening